RxDoctor Payments DataLook up a doctor →

Robert Garcia, MD

Child & Adolescent Psychiatry · Northville, MINPI 1184622136

Payments from drug & device makers

$23,514in general payments, 2019–2025

Across 1,402 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • AbbVie$2K
  • Jazz Pharmaceuticals Inc.$2K
  • Sunovion Pharmaceuticals Inc.$2K
  • Otsuka America Pharmaceutical, Inc.$2K
  • Lundbeck LLC$1K
  • plus $13K from 33 others

What the payments were for

  • Consulting fees$1751%
  • Food & beverage$22,94798%
  • Education$3912%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,514 in reported general payments places this provider in the 90th percentile of 73 child & adolescent psychiatry providers in Michigan.

See all child & adolescent psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$106,595
Medicare patients
157
Services billed
871

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl69$97,936
RexultiBrexpiprazole18$38,874
TrintellixVortioxetine Hydrobromide17$17,163
AuvelityDextromethorphan Hbr/Bupropion12$13,213
Lurasidone Hcl19$3,755
Desvenlafaxine Succinate ErDesvenlafaxine Succinate56$3,647
Quetiapine Fumarate107$3,287
Trazodone Hcl145$2,644
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine26$2,469
Bupropion XlBupropion Hcl139$2,379
Alprazolam371$2,250
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine89$2,193
Aripiprazole68$1,848
Fluvoxamine Maleate15$1,576
Venlafaxine Hcl ErVenlafaxine Hcl77$1,503

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,857$97,93669 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,755$38,87418 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$893$17,16317 claims
Axsome Therapeutics, Inc.Auvelity$1,014$13,21312 claims
Almatica Pharma LLCSertraline Hcl$314$70278 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 73 child & adolescent psychiatry providers in Michigan.

Other child & adolescent psychiatry in Northville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →